nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.297	1	CrCtD
Progesterone—CYP1A1—chronic obstructive pulmonary disease	0.0865	0.509	CbGaD
Progesterone—CYP1A2—chronic obstructive pulmonary disease	0.0834	0.491	CbGaD
Progesterone—NR3C2—Prednisolone—chronic obstructive pulmonary disease	0.0375	0.173	CbGbCtD
Progesterone—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0194	0.0897	CbGbCtD
Progesterone—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0194	0.0897	CbGbCtD
Progesterone—Potassium Canrenoate—Prednisone—chronic obstructive pulmonary disease	0.0158	0.0773	CrCrCtD
Progesterone—Potassium Canrenoate—Prednisolone—chronic obstructive pulmonary disease	0.0154	0.0754	CrCrCtD
Progesterone—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0147	0.0679	CbGbCtD
Progesterone—Danazol—Prednisone—chronic obstructive pulmonary disease	0.0133	0.0652	CrCrCtD
Progesterone—Medrysone—Prednisolone—chronic obstructive pulmonary disease	0.013	0.0637	CrCrCtD
Progesterone—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0124	0.0571	CbGbCtD
Progesterone—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0117	0.054	CbGbCtD
Progesterone—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.0116	0.0568	CrCrCtD
Progesterone—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.0113	0.0554	CrCrCtD
Progesterone—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.0112	0.055	CrCrCtD
Progesterone—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.011	0.0537	CrCrCtD
Progesterone—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.0109	0.0534	CrCrCtD
Progesterone—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.0106	0.0521	CrCrCtD
Progesterone—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.00978	0.0479	CrCrCtD
Progesterone—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00976	0.0478	CrCrCtD
Progesterone—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00953	0.0466	CrCrCtD
Progesterone—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.00952	0.0466	CrCrCtD
Progesterone—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.00929	0.0455	CrCrCtD
Progesterone—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.00864	0.0399	CbGbCtD
Progesterone—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.0083	0.0406	CrCrCtD
Progesterone—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.00827	0.0405	CrCrCtD
Progesterone—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.00804	0.0371	CbGbCtD
Progesterone—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.00804	0.0371	CbGbCtD
Progesterone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00796	0.039	CrCrCtD
Progesterone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00777	0.038	CrCrCtD
Progesterone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.00726	0.0335	CbGbCtD
Progesterone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.00668	0.0308	CbGbCtD
Progesterone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.00668	0.0308	CbGbCtD
Progesterone—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00631	0.0291	CbGbCtD
Progesterone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.00611	0.0282	CbGbCtD
Progesterone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.00611	0.0282	CbGbCtD
Progesterone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00545	0.0251	CbGbCtD
Progesterone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00513	0.0237	CbGbCtD
Progesterone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.00506	0.0234	CbGbCtD
Progesterone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00346	0.016	CbGbCtD
Progesterone—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00338	0.0156	CbGbCtD
Progesterone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0033	0.0152	CbGbCtD
Progesterone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00294	0.0136	CbGbCtD
Progesterone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00288	0.0133	CbGbCtD
Progesterone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00272	0.0126	CbGbCtD
Progesterone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00173	0.00797	CbGbCtD
Progesterone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00753	CbGbCtD
Progesterone—CYP17A1—connective tissue—chronic obstructive pulmonary disease	0.000378	0.0421	CbGeAlD
Progesterone—PGR—respiratory system—chronic obstructive pulmonary disease	0.000289	0.0321	CbGeAlD
Progesterone—SHBG—connective tissue—chronic obstructive pulmonary disease	0.000282	0.0314	CbGeAlD
Progesterone—NR3C2—connective tissue—chronic obstructive pulmonary disease	0.000273	0.0304	CbGeAlD
Progesterone—NR3C2—bronchus—chronic obstructive pulmonary disease	0.000256	0.0285	CbGeAlD
Progesterone—PGR—connective tissue—chronic obstructive pulmonary disease	0.000254	0.0283	CbGeAlD
Progesterone—NR3C2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00025	0.0278	CbGeAlD
Progesterone—CYP1B1—respiratory system—chronic obstructive pulmonary disease	0.000243	0.027	CbGeAlD
Progesterone—SLC22A3—connective tissue—chronic obstructive pulmonary disease	0.000233	0.0259	CbGeAlD
Progesterone—PGR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000233	0.0259	CbGeAlD
Progesterone—NR3C2—trachea—chronic obstructive pulmonary disease	0.00023	0.0256	CbGeAlD
Progesterone—ESR1—respiratory system—chronic obstructive pulmonary disease	0.000226	0.0251	CbGeAlD
Progesterone—CYP1B1—connective tissue—chronic obstructive pulmonary disease	0.000214	0.0238	CbGeAlD
Progesterone—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000213	0.0237	CbGeAlD
Progesterone—SIGMAR1—bronchus—chronic obstructive pulmonary disease	0.00021	0.0234	CbGeAlD
Progesterone—SIGMAR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000206	0.0229	CbGeAlD
Progesterone—AR—connective tissue—chronic obstructive pulmonary disease	0.000203	0.0225	CbGeAlD
Progesterone—ESR1—connective tissue—chronic obstructive pulmonary disease	0.000199	0.0221	CbGeAlD
Progesterone—CYP1B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000196	0.0218	CbGeAlD
Progesterone—AR—bronchus—chronic obstructive pulmonary disease	0.000189	0.0211	CbGeAlD
Progesterone—SIGMAR1—trachea—chronic obstructive pulmonary disease	0.000189	0.021	CbGeAlD
Progesterone—AR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000185	0.0206	CbGeAlD
Progesterone—ESR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000182	0.0202	CbGeAlD
Progesterone—ABCC1—bronchus—chronic obstructive pulmonary disease	0.00018	0.02	CbGeAlD
Progesterone—CYP2A6—lung—chronic obstructive pulmonary disease	0.000176	0.0196	CbGeAlD
Progesterone—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000174	0.0194	CbGeAlD
Progesterone—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000172	0.0191	CbGeAlD
Progesterone—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000168	0.0187	CbGeAlD
Progesterone—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.000167	0.0185	CbGeAlD
Progesterone—NR3C2—lung—chronic obstructive pulmonary disease	0.000165	0.0184	CbGeAlD
Progesterone—ABCC1—trachea—chronic obstructive pulmonary disease	0.000161	0.018	CbGeAlD
Progesterone—PGR—lung—chronic obstructive pulmonary disease	0.000153	0.0171	CbGeAlD
Progesterone—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.000147	0.0163	CbGeAlD
Progesterone—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000141	0.0157	CbGeAlD
Progesterone—SLC22A3—lung—chronic obstructive pulmonary disease	0.00014	0.0156	CbGeAlD
Progesterone—NR3C1—bronchus—chronic obstructive pulmonary disease	0.000137	0.0153	CbGeAlD
Progesterone—SIGMAR1—lung—chronic obstructive pulmonary disease	0.000136	0.0151	CbGeAlD
Progesterone—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000134	0.0149	CbGeAlD
Progesterone—CYP1B1—lung—chronic obstructive pulmonary disease	0.000129	0.0144	CbGeAlD
Progesterone—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000127	0.0141	CbGeAlD
Progesterone—NR3C1—trachea—chronic obstructive pulmonary disease	0.000123	0.0137	CbGeAlD
Progesterone—AR—lung—chronic obstructive pulmonary disease	0.000122	0.0136	CbGeAlD
Progesterone—ESR1—lung—chronic obstructive pulmonary disease	0.00012	0.0133	CbGeAlD
Progesterone—ABCC1—lung—chronic obstructive pulmonary disease	0.000116	0.0129	CbGeAlD
Progesterone—CYP1A2—lung—chronic obstructive pulmonary disease	9.24e-05	0.0103	CbGeAlD
Progesterone—CYP1A1—lung—chronic obstructive pulmonary disease	9.12e-05	0.0102	CbGeAlD
Progesterone—ABCB1—respiratory system—chronic obstructive pulmonary disease	8.92e-05	0.00993	CbGeAlD
Progesterone—CYP3A5—lung—chronic obstructive pulmonary disease	8.92e-05	0.00993	CbGeAlD
Progesterone—NR3C1—lung—chronic obstructive pulmonary disease	8.85e-05	0.00985	CbGeAlD
Progesterone—ABCB1—trachea—chronic obstructive pulmonary disease	6.59e-05	0.00734	CbGeAlD
Progesterone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	6.18e-05	0.000916	CcSEcCtD
Progesterone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	6.16e-05	0.000913	CcSEcCtD
Progesterone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	6.16e-05	0.000913	CcSEcCtD
Progesterone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	6.16e-05	0.000913	CcSEcCtD
Progesterone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	6.15e-05	0.000912	CcSEcCtD
Progesterone—Oedema—Montelukast—chronic obstructive pulmonary disease	6.15e-05	0.000911	CcSEcCtD
Progesterone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	6.15e-05	0.000911	CcSEcCtD
Progesterone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	6.13e-05	0.000908	CcSEcCtD
Progesterone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	6.13e-05	0.000908	CcSEcCtD
Progesterone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	6.11e-05	0.000906	CcSEcCtD
Progesterone—Infection—Montelukast—chronic obstructive pulmonary disease	6.11e-05	0.000906	CcSEcCtD
Progesterone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	6.1e-05	0.000904	CcSEcCtD
Progesterone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	6.1e-05	0.000904	CcSEcCtD
Progesterone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	6.08e-05	0.000901	CcSEcCtD
Progesterone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	6.05e-05	0.000896	CcSEcCtD
Progesterone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	6.03e-05	0.000894	CcSEcCtD
Progesterone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	6.02e-05	0.000892	CcSEcCtD
Progesterone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	5.97e-05	0.000885	CcSEcCtD
Progesterone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	5.93e-05	0.000879	CcSEcCtD
Progesterone—Oedema—Salbutamol—chronic obstructive pulmonary disease	5.93e-05	0.000879	CcSEcCtD
Progesterone—Infection—Salbutamol—chronic obstructive pulmonary disease	5.89e-05	0.000873	CcSEcCtD
Progesterone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	5.87e-05	0.00087	CcSEcCtD
Progesterone—Hypotension—Formoterol—chronic obstructive pulmonary disease	5.87e-05	0.00087	CcSEcCtD
Progesterone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	5.84e-05	0.000865	CcSEcCtD
Progesterone—Shock—Salbutamol—chronic obstructive pulmonary disease	5.83e-05	0.000864	CcSEcCtD
Progesterone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	5.82e-05	0.000863	CcSEcCtD
Progesterone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	5.81e-05	0.000862	CcSEcCtD
Progesterone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000861	CcSEcCtD
Progesterone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	5.79e-05	0.000858	CcSEcCtD
Progesterone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	5.76e-05	0.000853	CcSEcCtD
Progesterone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	5.73e-05	0.00085	CcSEcCtD
Progesterone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	5.73e-05	0.000849	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	5.72e-05	0.000848	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	5.72e-05	0.000848	CcSEcCtD
Progesterone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	5.68e-05	0.000842	CcSEcCtD
Progesterone—Insomnia—Formoterol—chronic obstructive pulmonary disease	5.68e-05	0.000842	CcSEcCtD
Progesterone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	5.65e-05	0.000838	CcSEcCtD
Progesterone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	5.64e-05	0.000837	CcSEcCtD
Progesterone—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000833	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	5.6e-05	0.00083	CcSEcCtD
Progesterone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	5.6e-05	0.00083	CcSEcCtD
Progesterone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	5.6e-05	0.00083	CcSEcCtD
Progesterone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	5.58e-05	0.000827	CcSEcCtD
Progesterone—Somnolence—Formoterol—chronic obstructive pulmonary disease	5.58e-05	0.000827	CcSEcCtD
Progesterone—Insomnia—Montelukast—chronic obstructive pulmonary disease	5.56e-05	0.000824	CcSEcCtD
Progesterone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	5.54e-05	0.000821	CcSEcCtD
Progesterone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	5.53e-05	0.000819	CcSEcCtD
Progesterone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	5.53e-05	0.000819	CcSEcCtD
Progesterone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	5.52e-05	0.000818	CcSEcCtD
Progesterone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	5.5e-05	0.000816	CcSEcCtD
Progesterone—Injury—Prednisone—chronic obstructive pulmonary disease	5.47e-05	0.000811	CcSEcCtD
Progesterone—Somnolence—Montelukast—chronic obstructive pulmonary disease	5.47e-05	0.00081	CcSEcCtD
Progesterone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	5.46e-05	0.000809	CcSEcCtD
Progesterone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	5.44e-05	0.000807	CcSEcCtD
Progesterone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	5.42e-05	0.000803	CcSEcCtD
Progesterone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	5.42e-05	0.000803	CcSEcCtD
Progesterone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	5.41e-05	0.000802	CcSEcCtD
Progesterone—Fatigue—Formoterol—chronic obstructive pulmonary disease	5.41e-05	0.000802	CcSEcCtD
Progesterone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	5.41e-05	0.000802	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	5.4e-05	0.000801	CcSEcCtD
Progesterone—Constipation—Formoterol—chronic obstructive pulmonary disease	5.37e-05	0.000796	CcSEcCtD
Progesterone—Pain—Formoterol—chronic obstructive pulmonary disease	5.37e-05	0.000796	CcSEcCtD
Progesterone—Pain—Arformoterol—chronic obstructive pulmonary disease	5.37e-05	0.000796	CcSEcCtD
Progesterone—Constipation—Arformoterol—chronic obstructive pulmonary disease	5.37e-05	0.000796	CcSEcCtD
Progesterone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	5.36e-05	0.000795	CcSEcCtD
Progesterone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	5.35e-05	0.000793	CcSEcCtD
Progesterone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	5.32e-05	0.000789	CcSEcCtD
Progesterone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	5.31e-05	0.000787	CcSEcCtD
Progesterone—Fatigue—Montelukast—chronic obstructive pulmonary disease	5.3e-05	0.000786	CcSEcCtD
Progesterone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	5.29e-05	0.000783	CcSEcCtD
Progesterone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	5.27e-05	0.000781	CcSEcCtD
Progesterone—Pain—Montelukast—chronic obstructive pulmonary disease	5.26e-05	0.000779	CcSEcCtD
Progesterone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	5.25e-05	0.000777	CcSEcCtD
Progesterone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	5.23e-05	0.000775	CcSEcCtD
Progesterone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	5.22e-05	0.000773	CcSEcCtD
Progesterone—Purpura—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000773	CcSEcCtD
Progesterone—Rash—Aminophylline—chronic obstructive pulmonary disease	5.2e-05	0.000771	CcSEcCtD
Progesterone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	5.2e-05	0.00077	CcSEcCtD
Progesterone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	5.18e-05	0.000768	CcSEcCtD
Progesterone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	5.17e-05	0.000767	CcSEcCtD
Progesterone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	5.17e-05	0.000767	CcSEcCtD
Progesterone—Headache—Aminophylline—chronic obstructive pulmonary disease	5.17e-05	0.000766	CcSEcCtD
Progesterone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	5.15e-05	0.000764	CcSEcCtD
Progesterone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	5.14e-05	0.000762	CcSEcCtD
Progesterone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	5.13e-05	0.000761	CcSEcCtD
Progesterone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	5.13e-05	0.000761	CcSEcCtD
Progesterone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	5.12e-05	0.000759	CcSEcCtD
Progesterone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	5.11e-05	0.000758	CcSEcCtD
Progesterone—Constipation—Salbutamol—chronic obstructive pulmonary disease	5.07e-05	0.000751	CcSEcCtD
Progesterone—Pain—Salbutamol—chronic obstructive pulmonary disease	5.07e-05	0.000751	CcSEcCtD
Progesterone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	5.03e-05	0.000745	CcSEcCtD
Progesterone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000745	CcSEcCtD
Progesterone—Urticaria—Formoterol—chronic obstructive pulmonary disease	4.99e-05	0.000739	CcSEcCtD
Progesterone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	4.99e-05	0.000739	CcSEcCtD
Progesterone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	4.96e-05	0.000736	CcSEcCtD
Progesterone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	4.96e-05	0.000736	CcSEcCtD
Progesterone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	4.96e-05	0.000736	CcSEcCtD
Progesterone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	4.96e-05	0.000736	CcSEcCtD
Progesterone—Affect lability—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.000733	CcSEcCtD
Progesterone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	4.95e-05	0.000733	CcSEcCtD
Progesterone—Rash—Tiotropium—chronic obstructive pulmonary disease	4.91e-05	0.000727	CcSEcCtD
Progesterone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	4.9e-05	0.000726	CcSEcCtD
Progesterone—Nausea—Aminophylline—chronic obstructive pulmonary disease	4.9e-05	0.000726	CcSEcCtD
Progesterone—Urticaria—Montelukast—chronic obstructive pulmonary disease	4.89e-05	0.000724	CcSEcCtD
Progesterone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	4.89e-05	0.000724	CcSEcCtD
Progesterone—Headache—Tiotropium—chronic obstructive pulmonary disease	4.87e-05	0.000722	CcSEcCtD
Progesterone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	4.86e-05	0.000721	CcSEcCtD
Progesterone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	4.86e-05	0.000721	CcSEcCtD
Progesterone—Face oedema—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.000719	CcSEcCtD
Progesterone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	4.85e-05	0.000719	CcSEcCtD
Progesterone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	4.81e-05	0.000713	CcSEcCtD
Progesterone—Irritability—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000711	CcSEcCtD
Progesterone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	4.79e-05	0.000709	CcSEcCtD
Progesterone—Mood swings—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000706	CcSEcCtD
Progesterone—ABCB1—lung—chronic obstructive pulmonary disease	4.74e-05	0.00527	CbGeAlD
Progesterone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	4.71e-05	0.000698	CcSEcCtD
Progesterone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	4.69e-05	0.000695	CcSEcCtD
Progesterone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	4.69e-05	0.000695	CcSEcCtD
Progesterone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	4.63e-05	0.000686	CcSEcCtD
Progesterone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	4.63e-05	0.000686	CcSEcCtD
Progesterone—Nausea—Tiotropium—chronic obstructive pulmonary disease	4.62e-05	0.000685	CcSEcCtD
Progesterone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	4.61e-05	0.000684	CcSEcCtD
Progesterone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	4.53e-05	0.000672	CcSEcCtD
Progesterone—Asthenia—Formoterol—chronic obstructive pulmonary disease	4.5e-05	0.000668	CcSEcCtD
Progesterone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	4.5e-05	0.000668	CcSEcCtD
Progesterone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	4.44e-05	0.000658	CcSEcCtD
Progesterone—Pruritus—Formoterol—chronic obstructive pulmonary disease	4.44e-05	0.000658	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000657	CcSEcCtD
Progesterone—Asthenia—Montelukast—chronic obstructive pulmonary disease	4.41e-05	0.000654	CcSEcCtD
Progesterone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000648	CcSEcCtD
Progesterone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	4.37e-05	0.000647	CcSEcCtD
Progesterone—Pruritus—Montelukast—chronic obstructive pulmonary disease	4.35e-05	0.000645	CcSEcCtD
Progesterone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	4.3e-05	0.000637	CcSEcCtD
Progesterone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	4.3e-05	0.000637	CcSEcCtD
Progesterone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	4.25e-05	0.00063	CcSEcCtD
Progesterone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	4.23e-05	0.000627	CcSEcCtD
Progesterone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	4.21e-05	0.000624	CcSEcCtD
Progesterone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	4.19e-05	0.000622	CcSEcCtD
Progesterone—Erythema—Prednisolone—chronic obstructive pulmonary disease	4.17e-05	0.000617	CcSEcCtD
Progesterone—Dizziness—Formoterol—chronic obstructive pulmonary disease	4.15e-05	0.000615	CcSEcCtD
Progesterone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	4.15e-05	0.000615	CcSEcCtD
Progesterone—Dizziness—Montelukast—chronic obstructive pulmonary disease	4.07e-05	0.000603	CcSEcCtD
Progesterone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	4.06e-05	0.000601	CcSEcCtD
Progesterone—Vomiting—Formoterol—chronic obstructive pulmonary disease	3.99e-05	0.000592	CcSEcCtD
Progesterone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	3.99e-05	0.000592	CcSEcCtD
Progesterone—Rash—Arformoterol—chronic obstructive pulmonary disease	3.96e-05	0.000587	CcSEcCtD
Progesterone—Rash—Formoterol—chronic obstructive pulmonary disease	3.96e-05	0.000587	CcSEcCtD
Progesterone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	3.96e-05	0.000586	CcSEcCtD
Progesterone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	3.96e-05	0.000586	CcSEcCtD
Progesterone—Weight increased—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000586	CcSEcCtD
Progesterone—Headache—Arformoterol—chronic obstructive pulmonary disease	3.93e-05	0.000583	CcSEcCtD
Progesterone—Headache—Formoterol—chronic obstructive pulmonary disease	3.93e-05	0.000583	CcSEcCtD
Progesterone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	3.93e-05	0.000583	CcSEcCtD
Progesterone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	3.93e-05	0.000582	CcSEcCtD
Progesterone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	3.92e-05	0.000581	CcSEcCtD
Progesterone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	3.92e-05	0.000581	CcSEcCtD
Progesterone—Vomiting—Montelukast—chronic obstructive pulmonary disease	3.91e-05	0.00058	CcSEcCtD
Progesterone—Rash—Montelukast—chronic obstructive pulmonary disease	3.88e-05	0.000575	CcSEcCtD
Progesterone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	3.87e-05	0.000574	CcSEcCtD
Progesterone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	3.87e-05	0.000573	CcSEcCtD
Progesterone—Depression—Prednisone—chronic obstructive pulmonary disease	3.86e-05	0.000573	CcSEcCtD
Progesterone—Headache—Montelukast—chronic obstructive pulmonary disease	3.85e-05	0.000571	CcSEcCtD
Progesterone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	3.81e-05	0.000564	CcSEcCtD
Progesterone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	3.8e-05	0.000563	CcSEcCtD
Progesterone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	3.77e-05	0.000559	CcSEcCtD
Progesterone—Malaise—Prednisolone—chronic obstructive pulmonary disease	3.76e-05	0.000557	CcSEcCtD
Progesterone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	3.74e-05	0.000555	CcSEcCtD
Progesterone—Rash—Salbutamol—chronic obstructive pulmonary disease	3.74e-05	0.000554	CcSEcCtD
Progesterone—Syncope—Prednisolone—chronic obstructive pulmonary disease	3.74e-05	0.000554	CcSEcCtD
Progesterone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	3.73e-05	0.000553	CcSEcCtD
Progesterone—Nausea—Formoterol—chronic obstructive pulmonary disease	3.73e-05	0.000553	CcSEcCtD
Progesterone—Nausea—Arformoterol—chronic obstructive pulmonary disease	3.73e-05	0.000553	CcSEcCtD
Progesterone—Headache—Salbutamol—chronic obstructive pulmonary disease	3.71e-05	0.00055	CcSEcCtD
Progesterone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	3.66e-05	0.000543	CcSEcCtD
Progesterone—Nausea—Montelukast—chronic obstructive pulmonary disease	3.65e-05	0.000541	CcSEcCtD
Progesterone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	3.61e-05	0.000535	CcSEcCtD
Progesterone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	3.6e-05	0.000533	CcSEcCtD
Progesterone—Nausea—Salbutamol—chronic obstructive pulmonary disease	3.52e-05	0.000522	CcSEcCtD
Progesterone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	3.5e-05	0.000519	CcSEcCtD
Progesterone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	3.5e-05	0.000518	CcSEcCtD
Progesterone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.000515	CcSEcCtD
Progesterone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	3.42e-05	0.000507	CcSEcCtD
Progesterone—Oedema—Prednisolone—chronic obstructive pulmonary disease	3.4e-05	0.000504	CcSEcCtD
Progesterone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	3.4e-05	0.000504	CcSEcCtD
Progesterone—Shock—Prednisolone—chronic obstructive pulmonary disease	3.35e-05	0.000496	CcSEcCtD
Progesterone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	3.32e-05	0.000492	CcSEcCtD
Progesterone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	3.29e-05	0.000487	CcSEcCtD
Progesterone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	3.25e-05	0.000482	CcSEcCtD
Progesterone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	3.16e-05	0.000468	CcSEcCtD
Progesterone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000466	CcSEcCtD
Progesterone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	3.08e-05	0.000456	CcSEcCtD
Progesterone—Alopecia—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000455	CcSEcCtD
Progesterone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	3.05e-05	0.000453	CcSEcCtD
Progesterone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	3.05e-05	0.000452	CcSEcCtD
Progesterone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	3.03e-05	0.000449	CcSEcCtD
Progesterone—Erythema—Prednisone—chronic obstructive pulmonary disease	3.03e-05	0.000449	CcSEcCtD
Progesterone—Pain—Prednisolone—chronic obstructive pulmonary disease	2.91e-05	0.000431	CcSEcCtD
Progesterone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	2.85e-05	0.000423	CcSEcCtD
Progesterone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	2.81e-05	0.000416	CcSEcCtD
Progesterone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	2.8e-05	0.000415	CcSEcCtD
Progesterone—Anaemia—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000415	CcSEcCtD
Progesterone—Angioedema—Prednisone—chronic obstructive pulmonary disease	2.77e-05	0.00041	CcSEcCtD
Progesterone—Malaise—Prednisone—chronic obstructive pulmonary disease	2.73e-05	0.000405	CcSEcCtD
Progesterone—Vertigo—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.000403	CcSEcCtD
Progesterone—Syncope—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.000402	CcSEcCtD
Progesterone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	2.7e-05	0.0004	CcSEcCtD
Progesterone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	2.66e-05	0.000394	CcSEcCtD
Progesterone—Convulsion—Prednisone—chronic obstructive pulmonary disease	2.62e-05	0.000389	CcSEcCtD
Progesterone—Hypertension—Prednisone—chronic obstructive pulmonary disease	2.61e-05	0.000387	CcSEcCtD
Progesterone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	2.58e-05	0.000382	CcSEcCtD
Progesterone—Myalgia—Prednisone—chronic obstructive pulmonary disease	2.58e-05	0.000382	CcSEcCtD
Progesterone—Anxiety—Prednisone—chronic obstructive pulmonary disease	2.57e-05	0.000381	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	2.56e-05	0.000379	CcSEcCtD
Progesterone—Discomfort—Prednisone—chronic obstructive pulmonary disease	2.55e-05	0.000377	CcSEcCtD
Progesterone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	2.51e-05	0.000371	CcSEcCtD
Progesterone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	2.47e-05	0.000366	CcSEcCtD
Progesterone—Oedema—Prednisone—chronic obstructive pulmonary disease	2.47e-05	0.000366	CcSEcCtD
Progesterone—Infection—Prednisone—chronic obstructive pulmonary disease	2.45e-05	0.000364	CcSEcCtD
Progesterone—Shock—Prednisone—chronic obstructive pulmonary disease	2.43e-05	0.00036	CcSEcCtD
Progesterone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	2.42e-05	0.000359	CcSEcCtD
Progesterone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	2.41e-05	0.000357	CcSEcCtD
Progesterone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	2.4e-05	0.000356	CcSEcCtD
Progesterone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	2.39e-05	0.000354	CcSEcCtD
Progesterone—Anorexia—Prednisone—chronic obstructive pulmonary disease	2.36e-05	0.000349	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.25e-05	0.000334	CcSEcCtD
Progesterone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.25e-05	0.000333	CcSEcCtD
Progesterone—Insomnia—Prednisone—chronic obstructive pulmonary disease	2.23e-05	0.000331	CcSEcCtD
Progesterone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	2.22e-05	0.000329	CcSEcCtD
Progesterone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	2.18e-05	0.000322	CcSEcCtD
Progesterone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	2.15e-05	0.000318	CcSEcCtD
Progesterone—Rash—Prednisolone—chronic obstructive pulmonary disease	2.14e-05	0.000318	CcSEcCtD
Progesterone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.14e-05	0.000317	CcSEcCtD
Progesterone—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.13e-05	0.000316	CcSEcCtD
Progesterone—Headache—Prednisolone—chronic obstructive pulmonary disease	2.13e-05	0.000316	CcSEcCtD
Progesterone—Constipation—Prednisone—chronic obstructive pulmonary disease	2.11e-05	0.000313	CcSEcCtD
Progesterone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	2.04e-05	0.000302	CcSEcCtD
Progesterone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.02e-05	0.000299	CcSEcCtD
Progesterone—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.02e-05	0.000299	CcSEcCtD
Progesterone—Urticaria—Prednisone—chronic obstructive pulmonary disease	1.96e-05	0.000291	CcSEcCtD
Progesterone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	1.95e-05	0.000289	CcSEcCtD
Progesterone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	1.95e-05	0.000289	CcSEcCtD
Progesterone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	1.82e-05	0.00027	CcSEcCtD
Progesterone—Asthenia—Prednisone—chronic obstructive pulmonary disease	1.77e-05	0.000263	CcSEcCtD
Progesterone—Pruritus—Prednisone—chronic obstructive pulmonary disease	1.75e-05	0.000259	CcSEcCtD
Progesterone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	1.69e-05	0.000251	CcSEcCtD
Progesterone—Dizziness—Prednisone—chronic obstructive pulmonary disease	1.63e-05	0.000242	CcSEcCtD
Progesterone—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.57e-05	0.000233	CcSEcCtD
Progesterone—Rash—Prednisone—chronic obstructive pulmonary disease	1.56e-05	0.000231	CcSEcCtD
Progesterone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.56e-05	0.000231	CcSEcCtD
Progesterone—Headache—Prednisone—chronic obstructive pulmonary disease	1.55e-05	0.000229	CcSEcCtD
Progesterone—Nausea—Prednisone—chronic obstructive pulmonary disease	1.47e-05	0.000218	CcSEcCtD
Progesterone—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.78e-06	0.000165	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.75e-06	0.000164	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.75e-06	0.000164	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	5.74e-06	0.000164	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.74e-06	0.000164	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.7e-06	0.000162	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	5.69e-06	0.000162	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.68e-06	0.000162	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.59e-06	0.000159	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.56e-06	0.000158	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.56e-06	0.000158	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.53e-06	0.000157	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.52e-06	0.000157	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.49e-06	0.000156	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.48e-06	0.000156	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.47e-06	0.000156	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.47e-06	0.000156	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.45e-06	0.000155	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	5.41e-06	0.000154	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	5.37e-06	0.000153	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.35e-06	0.000152	CbGpPWpGaD
Progesterone—PGR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	5.34e-06	0.000152	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.34e-06	0.000152	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.3e-06	0.000151	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.3e-06	0.000151	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.29e-06	0.000151	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.27e-06	0.00015	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.21e-06	0.000148	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	5.19e-06	0.000148	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.18e-06	0.000147	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.17e-06	0.000147	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.07e-06	0.000144	CbGpPWpGaD
Progesterone—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.03e-06	0.000143	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.03e-06	0.000143	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.99e-06	0.000142	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.95e-06	0.000141	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.88e-06	0.000139	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.83e-06	0.000137	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.78e-06	0.000136	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.77e-06	0.000136	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.77e-06	0.000136	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.77e-06	0.000136	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.76e-06	0.000136	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.76e-06	0.000135	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.71e-06	0.000134	CbGpPWpGaD
Progesterone—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.69e-06	0.000134	CbGpPWpGaD
Progesterone—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	4.61e-06	0.000131	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	4.59e-06	0.000131	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.58e-06	0.00013	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.57e-06	0.00013	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.51e-06	0.000128	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.49e-06	0.000128	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.45e-06	0.000127	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.43e-06	0.000126	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.42e-06	0.000126	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.38e-06	0.000125	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.38e-06	0.000125	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.36e-06	0.000124	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.36e-06	0.000124	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.3e-06	0.000122	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.3e-06	0.000122	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.29e-06	0.000122	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.26e-06	0.000121	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.26e-06	0.000121	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.2e-06	0.00012	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.17e-06	0.000119	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.16e-06	0.000118	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	4.11e-06	0.000117	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.09e-06	0.000116	CbGpPWpGaD
Progesterone—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.07e-06	0.000116	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.06e-06	0.000116	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.99e-06	0.000114	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.98e-06	0.000113	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.98e-06	0.000113	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.97e-06	0.000113	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.93e-06	0.000112	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.93e-06	0.000112	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.93e-06	0.000112	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.9e-06	0.000111	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.88e-06	0.000111	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.88e-06	0.00011	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.88e-06	0.00011	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.85e-06	0.00011	CbGpPWpGaD
Progesterone—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	3.85e-06	0.000109	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—ALB—chronic obstructive pulmonary disease	3.76e-06	0.000107	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.75e-06	0.000107	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.73e-06	0.000106	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.71e-06	0.000106	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.66e-06	0.000104	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.66e-06	0.000104	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.66e-06	0.000104	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.66e-06	0.000104	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.64e-06	0.000104	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.62e-06	0.000103	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.61e-06	0.000103	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.6e-06	0.000103	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—ALB—chronic obstructive pulmonary disease	3.6e-06	0.000103	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.6e-06	0.000103	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.6e-06	0.000102	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.58e-06	0.000102	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.56e-06	0.000101	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.54e-06	0.000101	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.54e-06	0.000101	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.48e-06	9.89e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.47e-06	9.89e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.47e-06	9.87e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.47e-06	9.87e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.46e-06	9.84e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—NOS3—chronic obstructive pulmonary disease	3.45e-06	9.81e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.41e-06	9.71e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.4e-06	9.67e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.36e-06	9.56e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.32e-06	9.45e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.32e-06	9.44e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.29e-06	9.37e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.27e-06	9.29e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	3.25e-06	9.25e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	3.24e-06	9.22e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.23e-06	9.2e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.22e-06	9.15e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.2e-06	9.1e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.18e-06	9.06e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	3.18e-06	9.05e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.14e-06	8.93e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.14e-06	8.93e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.1e-06	8.83e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	3.09e-06	8.8e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.09e-06	8.79e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.99e-06	8.52e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.96e-06	8.44e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.96e-06	8.42e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.94e-06	8.38e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.93e-06	8.35e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.92e-06	8.32e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.9e-06	8.27e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.9e-06	8.26e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.9e-06	8.25e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.88e-06	8.21e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.85e-06	8.12e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.84e-06	8.09e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.83e-06	8.06e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.8e-06	7.96e-05	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.75e-06	7.83e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.72e-06	7.75e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.72e-06	7.75e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	2.71e-06	7.71e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.7e-06	7.69e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.69e-06	7.65e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.67e-06	7.61e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.67e-06	7.59e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.66e-06	7.58e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.65e-06	7.54e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.64e-06	7.53e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	2.62e-06	7.45e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.61e-06	7.42e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.6e-06	7.4e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.6e-06	7.4e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.59e-06	7.37e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.51e-06	7.15e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.51e-06	7.13e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.5e-06	7.13e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.5e-06	7.12e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.5e-06	7.11e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.48e-06	7.05e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.46e-06	7.01e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.46e-06	7e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.44e-06	6.94e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.39e-06	6.8e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	2.36e-06	6.72e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.36e-06	6.71e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.31e-06	6.57e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.3e-06	6.56e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.29e-06	6.53e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.26e-06	6.43e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	2.26e-06	6.43e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.26e-06	6.42e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.23e-06	6.34e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.2e-06	6.26e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.2e-06	6.26e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.19e-06	6.24e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.19e-06	6.24e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.18e-06	6.19e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.18e-06	6.19e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	2.16e-06	6.16e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.15e-06	6.12e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.15e-06	6.11e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.1e-06	5.98e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.08e-06	5.93e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.07e-06	5.89e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.05e-06	5.83e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.05e-06	5.83e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	2.04e-06	5.82e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.04e-06	5.81e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.03e-06	5.78e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.02e-06	5.75e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	2e-06	5.71e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2e-06	5.7e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2e-06	5.69e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.95e-06	5.54e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.94e-06	5.53e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.93e-06	5.5e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.91e-06	5.44e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.89e-06	5.39e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.88e-06	5.36e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.87e-06	5.33e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.87e-06	5.32e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.81e-06	5.14e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.79e-06	5.08e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.77e-06	5.04e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.74e-06	4.96e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.74e-06	4.94e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.73e-06	4.92e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.72e-06	4.89e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.71e-06	4.87e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.71e-06	4.86e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.68e-06	4.8e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.65e-06	4.71e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.63e-06	4.65e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.61e-06	4.59e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.61e-06	4.57e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.6e-06	4.54e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.56e-06	4.45e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.54e-06	4.39e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	1.54e-06	4.39e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.51e-06	4.31e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.48e-06	4.21e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.41e-06	4.03e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.41e-06	4.03e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.4e-06	3.99e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.34e-06	3.81e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.32e-06	3.76e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.32e-06	3.76e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.29e-06	3.69e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.29e-06	3.67e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.29e-06	3.67e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.26e-06	3.59e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-06	3.59e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.23e-06	3.51e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.23e-06	3.51e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.21e-06	3.46e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.2e-06	3.43e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.17e-06	3.32e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-06	3.31e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.15e-06	3.28e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.06e-06	3.02e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-06	2.93e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.84e-07	2.8e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.7e-07	2.76e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.94e-07	2.26e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.59e-07	2.16e-05	CbGpPWpGaD
